These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21098647)

  • 1. Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
    Curran RE; Claxton CR; Hutchison L; Harradine PJ; Martin IJ; Littlewood P
    Drug Metab Dispos; 2011 Mar; 39(3):551-7. PubMed ID: 21098647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH lability in serum during equilibrium dialysis.
    Brørs O; Jacobsen S
    Br J Clin Pharmacol; 1985 Jul; 20(1):85-8. PubMed ID: 4027141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a higher-throughput equilibrium dialysis assay for plasma protein binding.
    van Liempd S; Morrison D; Sysmans L; Nelis P; Mortishire-Smith R
    J Lab Autom; 2011 Feb; 16(1):56-67. PubMed ID: 21609686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Protein Binding of Challenging Compounds.
    Riccardi K; Cawley S; Yates PD; Chang C; Funk C; Niosi M; Lin J; Di L
    J Pharm Sci; 2015 Aug; 104(8):2627-36. PubMed ID: 26037784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of recovery on fraction unbound using equilibrium dialysis.
    Di L; Umland JP; Trapa PE; Maurer TS
    J Pharm Sci; 2012 Mar; 101(3):1327-35. PubMed ID: 22161810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Errors in interpretation of data from equilibrium dialysis protein binding experiments.
    Behm HL; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):145-60. PubMed ID: 515500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry.
    Wan H; Rehngren M
    J Chromatogr A; 2006 Jan; 1102(1-2):125-34. PubMed ID: 16266710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of drug plasma protein binding by solid phase microextraction.
    Musteata FM; Pawliszyn J; Qian MG; Wu JT; Miwa GT
    J Pharm Sci; 2006 Aug; 95(8):1712-22. PubMed ID: 16795010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the measurement of lidocaine protein binding by equilibrium dialysis in human serum.
    Ponganis KV; Stanski DR
    J Pharm Sci; 1985 Jan; 74(1):57-60. PubMed ID: 3981419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the protein binding of bumetanide using an equilibrium dialysis technique.
    Shim HJ; Lee MG; Lee MH
    J Clin Pharm Ther; 1991 Dec; 16(6):467-76. PubMed ID: 1770075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs.
    Zamek-Gliszczynski MJ; Ruterbories KJ; Ajamie RT; Wickremsinhe ER; Pothuri L; Rao MV; Basavanakatti VN; Pinjari J; Ramanathan VK; Chaudhary AK
    J Pharm Sci; 2011 Jun; 100(6):2498-507. PubMed ID: 21213309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput determination of the free fraction of drugs strongly bound to plasma proteins.
    Schuhmacher J; Kohlsdorfer C; Bühner K; Brandenburger T; Kruk R
    J Pharm Sci; 2004 Apr; 93(4):816-30. PubMed ID: 14999720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
    Weiss HM; Gatlik E
    J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis.
    Brørs O; Sager G; Sandnes D; Jacobsen S
    Br J Clin Pharmacol; 1983 Apr; 15(4):393-7. PubMed ID: 6849773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of highly bound drugs: interspecies, intersubject, and related comparisons.
    Collins JM; Klecker RW
    J Clin Pharmacol; 2002 Sep; 42(9):971-5. PubMed ID: 12211222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioanalytical challenge of determining unbound concentration and protein binding for drugs.
    Nilsson LB
    Bioanalysis; 2013 Dec; 5(24):3033-50. PubMed ID: 24320129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.
    Kurz H; Trunk H; Weitz B
    Arzneimittelforschung; 1977 Jul; 27(7):1373-80. PubMed ID: 578456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.